Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Manufacture and Trading of Surgical Implants, Instruments and Related Products	-	-	1.21B	1.20B	1.11B
Manufacture and Trading of Surgical Implants, Instruments and Related Products Growth	-	-	0.58%	8.43%	18.18%
Medical Device Products	1.04B	805.22M	-	-	-
Medical Device Products Growth	29.77%	-	-	-	-
Unallocated Other	799.40K	641.12K	-	-	-
Unallocated Other Growth	24.69%	-	-	-	-
Total	1.05B	805.86M	1.21B	1.20B	1.11B
Total Growth	29.77%	-33.32%	0.58%	8.43%	18.18%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	556.74M	-	-	-	-
Overseas	488.23M	-	-	-	-
Total	1.04B	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error